Ginsenoside Rg1 protects hydrogen peroxide-induced PC12 cell death: involvement of NMMHC IIA-NF-κB/p65 pathway (1143.15)

junping kou,qian liu,teng guan,yan wang,yanni lv,yalin huang,zhengyu cao,boyang yu

DOI: https://doi.org/10.1096/fasebj.28.1_supplement.1143.15

2014-01-01

The FASEB Journal

Abstract:Neuronal oxidative stress is a primary mechanism of neuron loss and neurological dysfunction in several CNS diseases. Our previous study demonstrated that ginsenoside Rg1 (Rg1) afforded neuroprotection against oxidative injury by attenuating the over‐activation of NF‐kappaB/p65, ERK1/2 and Akt signalling pathways. To further investigate how Rg1 regulates the NF‐kappaB/p65 activation, we explored the molecular targets for Rg1 through which Rg1 exerts neuroprotective activity. Using the serial affinity chromatography, we identified the non‐muscle myosin heavy chain IIA (NMMHC IIA) as one of the Rg1 specific binding proteins in PC12 cells. To understand the Rg1‐NMMHC IIA binding complex structure, we employed computer‐aided homology modelling to illustrate how the small molecule interacts with the protein based on the structure of the NMMHC IIA modelled with 1BR2 and 1YV3 (PDB coded). The pharmacological inhibitor of NMMHC IIA, blebbistatin, and NMMHC IIA ShRNA both blocked Rg1’s neuroptection on oxidative stress‐induced NF‐kappaB/p65 activation and cell death suggesting NMMHC IIA was a potential target for Rg1 neuroprotection against neuronal oxidative stress. In addition, Rg1 normalized the oxidative stress‐induced NMMCH IIA over‐expression in PC12 cells. Considered these data together suggested that NMMHC IIA‐NF‐kappaB/p65 pathway involved in oxidative stress‐induced cell death. This novel identified pathway may potentially explain the neuroprotective mechanism of Rg1 against oxidative damage in several CNS diseases. Our results therefore may help to understand the pathophysiology of oxidative stress and the molecular mechanisms of Rg1 neuroprotection.